Literature DB >> 34486677

LINC00937 suppresses keloid fibroblast proliferation and extracellular matrix deposition by targeting the miR-28-5p/MC1R axis.

Jing Wan1, Xiao-Lei He1, Qi-Chao Jian2, Zhi-Feng Fan1, Ying Shi1, Long-Fei Luo3.   

Abstract

Long noncoding RNAs (lncRNAs) are the most recently discovered class of noncoding RNAs. LncRNAs play a crucial role in multiple disorders. However, the role and mechanism of action of lncRNAs in keloids remain unclear. Here, qRT-PCR and western blotting assays were performed to determine the expression of genes and proteins, respectively. MTT assays were carried out to measure the proliferation of keloid fibroblasts. In addition, a luciferase activity assay was conducted to investigate the relationships between LINC00937 and miR-28-5p and between miR-28-5p and MC1R. The results showed that LINC00937 and MC1R were decreased, whereas miR-28-5p was increased in keloid tissues. LINC00937 overexpression in keloid fibroblasts could repress the extracellular matrix (ECM) deposition and cell proliferation and promote MC1R expression. Moreover, high expression of miR-28-5p and low expression of LINC00937 were detected in keloid fibroblasts. We further showed that LINC00937 promoted MC1R expression by sponging miR-28-5p. Finally, our data indicated that LINC00937 inhibited the ECM deposition and proliferation of keloid fibroblasts by inhibiting miR-28-5p and facilitating MC1R expression. Overall, LINC00937 suppressed the ECM deposition and proliferation of keloid fibroblasts by acting as an miR-28-5p sponge and promoting MC1R expression. Our data suggested that LINC00937 is a potential target for keloid treatment.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34486677     DOI: 10.14670/HH-18-372

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  25 in total

Review 1.  Long non-coding RNA in cervical cancer: From biology to therapeutic opportunity.

Authors:  Jiaxing He; Bingyu Huang; Kun Zhang; Mubiao Liu; Tianmin Xu
Journal:  Biomed Pharmacother       Date:  2020-05-20       Impact factor: 6.529

Review 2.  Fibroblasts and the extracellular matrix in right ventricular disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2017-10-01       Impact factor: 10.787

Review 3.  From genetics to epigenetics: new insights into keloid scarring.

Authors:  Yongjing He; Zhenjun Deng; Mansour Alghamdi; Lechun Lu; Mark W Fear; Li He
Journal:  Cell Prolif       Date:  2017-01-05       Impact factor: 6.831

4.  Long noncoding RNA TUG1 alleviates extracellular matrix accumulation via mediating microRNA-377 targeting of PPARγ in diabetic nephropathy.

Authors:  Li-Jun Duan; Min Ding; Li-Jun Hou; Yuan-Tao Cui; Chun-Jun Li; De-Min Yu
Journal:  Biochem Biophys Res Commun       Date:  2017-01-28       Impact factor: 3.575

Review 5.  Melanocortins in fibroblast biology--current update and future perspective for dermatology.

Authors:  Markus Böhm; Thomas A Luger
Journal:  Exp Dermatol       Date:  2004       Impact factor: 3.960

6.  Bleomycin-induced fibrosis in MC1 signalling-deficient C57BL/6J-Mc1r(e/e) mice further supports a modulating role for melanocortins in collagen synthesis of the skin.

Authors:  Markus Böhm; Agatha Stegemann
Journal:  Exp Dermatol       Date:  2014-06       Impact factor: 3.960

7.  Pigmentation Diathesis of Hypertrophic Scar: An Examination of Known Signaling Pathways to Elucidate the Molecular Pathophysiology of Injury-Related Dyschromia.

Authors:  Bonnie C Carney; Jason H Chen; Jenna N Luker; Abdulnaser Alkhalil; Daniel Y Jo; Taryn E Travis; Lauren T Moffatt; Cynthia M Simbulan-Rosenthal; Dean S Rosenthal; Jeffrey W Shupp
Journal:  J Burn Care Res       Date:  2019-01-01       Impact factor: 1.845

Review 8.  Keloids: The paradigm of skin fibrosis - Pathomechanisms and treatment.

Authors:  Jonathan P Andrews; Jaana Marttala; Edward Macarak; Joel Rosenbloom; Jouni Uitto
Journal:  Matrix Biol       Date:  2016-02-02       Impact factor: 11.583

9.  Collagen metabolism is a novel target of the neuropeptide alpha-melanocyte-stimulating hormone.

Authors:  Markus Böhm; Michael Raghunath; Cord Sunderkötter; Meinhard Schiller; Sonja Ständer; Thomas Brzoska; Thomas Cauvet; Helgi B Schiöth; Thomas Schwarz; Thomas A Luger
Journal:  J Biol Chem       Date:  2003-11-28       Impact factor: 5.157

10.  Targeting MC1R depalmitoylation to prevent melanomagenesis in redheads.

Authors:  Shuyang Chen; Changpeng Han; Xiao Miao; Xin Li; Chengqian Yin; Junrong Zou; Min Liu; Shanshan Li; Lukasz Stawski; Bo Zhu; Qiong Shi; Zhi-Xiang Xu; Chunying Li; Colin R Goding; Jun Zhou; Rutao Cui
Journal:  Nat Commun       Date:  2019-02-20       Impact factor: 14.919

View more
  3 in total

Review 1.  Advances in the pathogenesis and clinical application prospects of tumor biomolecules in keloid.

Authors:  Yijun Xia; Youbin Wang; Mengjie Shan; Yan Hao; Hao Liu; Qiao Chen; Zhengyun Liang
Journal:  Burns Trauma       Date:  2022-06-25

Review 2.  Emerging roles of long non-coding RNAs in keloids.

Authors:  Xin Yu; Xueqing Zhu; Hongjun Xu; Linfeng Li
Journal:  Front Cell Dev Biol       Date:  2022-08-15

3.  LINC00452 overexpression reverses oxLDL-induced injury of human umbilical vein endothelial cells (HUVECs) via regulating miR-194-5p/IGF1R axis.

Authors:  Liang Yuan; Dajie Wang; Zhaofeng Zhou
Journal:  Front Cardiovasc Med       Date:  2022-09-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.